Compare Charlie Hospital Semarang Tbk. (RSCH) vs Reksa Dana Danareksa ETF Indonesia Top 40 (XDIF) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Charlie Hospital Semarang Tbk. vs Reksa Dana Danareksa ETF Indonesia Top 40 — how do they compare? Charlie Hospital Semarang Tbk. trades at Rp268 (market cap 715.5B, 23.56M 24h volume), while Reksa Dana Danareksa ETF Indonesia Top 40 trades at Rp422 (market cap 30.55B). The key difference: Charlie Hospital Semarang Tbk. is far larger — about 23.4× Reksa Dana Danareksa ETF Indonesia Top 40's market cap. Which is the better fit depends on your goals.
| RSCH | XDIF | |
|---|---|---|
Market Cap | 715.5B | 30.55B |
Volume | 23.56M | — |
Lot | 235.61K | — |
Turnover | 6.3B | — |
Average Price | 267.58 | — |
Value | 6.3B | — |
Indicative Equilibrium Price | 268 | — |
Indicative Equilibrium Volume | 70 | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Charlie Hospital Semarang Tbk.
PT Charlie Hospital Semarang, Tbk (the "Company") was established based on Deed No. 35 dated 11 February 2019, which was made before Notary Nur Hadi, SH, MKn, notary in Kendal Regency and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia based on Decree No. AHU-0008598.AH.01.01. Year 2019 February 11, 2019. The company started its commercial operations on September 23, 2019.
Read more on RSCH →
